BASHH National Audit Group
Clinic Policy Audit on the Management of First Episode Anogenital Warts
BASHH Clinical Effectiveness Group Auditable Outcome Measures (2007):
The use of a treatment protocol has been shown to improve the management of genital warts. It is
recommended that a continuing audit cycle is adopted to ensure effective use of a protocol and for the
incorporation of any new treatments available.
Recommended outcomes are:
• Adherence to protocol, 90% of patients
• Percentage of patients with original wart clearance at 3 months; 90%
Five essential questions are: Qs 3, 4, 5, 12, 13 highlighted in yellow
Q.1a: Type of clinic. Please tick all that apply:
District general hospital

Teaching hospital

Community-based service

Other
 Please specify:
Q.1b: Name of organisation:
Q.2a: Annual male clinic attendances (new and re-book episodes):
Q.2b: Annual female clinic attendances (new and re-book episodes):
Q.2c: Total number of male patients seen with anogenital warts (AGW) in your clinic
during <please state audit interval>:
Q.2d: Total number of female patients seen with AGW in your clinic during <please
state audit interval>:
Q3: Does your clinic routinely use a protocol or treatment algorithm for the management of
AGW?
 Yes  No
Q.4: Are anatomical, including on electronic patient records, maps/diagrams routinely used in
your clinic for recording the sites of AGW?
 Yes  No
Q.5: What is your clinic policy regarding cervical cytology to immunocompetent
women aged >25 years presenting with vulval warts?
Not offered

Offered regardless of when cytology obtained

Offered only if last obtained more than 3-5 years ago

Women advised to arrange cervical cytology with their GP
if last obtained more than 3-5 years ago

If patient agrees, letter sent to GP to arrange cervical cytology
if last obtained more than 3-5 years ago

Other policy
 Please specify:
Page 1 of 4
BASHH National Audit Group
Q.6: Which of the following treatments for AGW does your clinic routinely offer?
Please tick all that apply (more than one box in each line is possible):
First line
Cryotherapy, open (liquid nitrogen)
Cryotherapy, closed
Podophyllotoxin, topical
Imiquimod, topical
Podophyllum, topical
Trichloroacetic acid
Surgical/scissor excision
Electrocautery/electrotherapy
Loop electrical excision procedure
Laser therapy










Second
line










Third line










Fourth
line










Not
offered










Q.7: Which of the following factors routinely influence the choice of treatment for
AGW in your clinic? Please indicate the factors influencing each treatment used
Cryotherapy,
open (liquid
nitrogen)
Cryotherapy,
closed
Podophyllotoxin,
topical
Imiquimod,
topical
Podophyllum,
topical
Trichloroacetic
acid
Surgical/scissor
excision
Electrocautery/
electrotherapy
Loop electrical
excision
procedure
Laser therapy
Number
of warts
Total
wart
volu
me
Patient
choice
Cost
factors
Availability
of staff
trained to
provide this
treatment
Not
offered




























































Other, please specify
below:
Q.8a: What is your clinic policy regarding review in your clinic after providing selfapplied treatment? Please tick all that apply:
All patients offered review
Selected patients offered review
Patients asked to arrange review if warts persist
Yes 
Yes 
Yes 
Page 2 of 4
No 
No 
No 
BASHH National Audit Group
Yes 
Yes 
No patients offered review
Other
No 
Please specify:
Q.8b: If patients are offered clinic review following self-applied treatment, please
specify the timescale of the first review:
 4 weeks
 8 weeks
 12 weeks  Other, please specify:
Q.8c: What is your clinic policy regarding review in your clinic after clinic-based
treatment? Please tick all that apply:
All patients offered review
Selected patients offered review
Patients asked to arrange review if warts persist
No patients offered review
Other
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
Please specify:
Q.8d: If patients are offered clinic review following clinic-based treatment, please
specify the timescale of the first review:
 4 weeks
 8 weeks
 12 weeks  Other, please specify:
Q.9: Is it your clinic policy routinely to document the outcome of treatment for AGW at
three months in your clinic?
 Yes
 No
Q.10a: Are patients diagnosed with AGW routinely offered information on AGW in
your clinic?
 Yes
 No
Q10b: If Yes, is advice given to use condoms for the purpose of preventing human
papillomavirus transmission in any of the following situations?
Please tick all that apply:
Information
Verbal
discussion
documented

Written
information
provided

Patient in in a current relationship with a sexual partner who does have AGW


If patient has a new sexual partner who does not have AGW


If patient has a new sexual partner who does have AGW




Patient in a current relationship with a sexual partner who does not have AGW
Other, please specify:
Page 3 of 4
BASHH National Audit Group
Q.11: Is it your clinic policy routinely to offer partner notification, specifically for
AGW, for patients with first episode AGW, and when no other infections are detected,
in your clinic?
 Yes
 No
Q.12a: Does your clinic have a written policy, protocol, treatment guideline, care
pathway or other document dealing with the management of AGW?
 Yes
 No
Q.12b: If Yes, is this based on the BASHH Guideline for the management of AGW?
 Yes
 No
Q.13: Please provide any additional comments about the management of AGW in your clinic:
Last modified 18 March 2011. Hugo McClean, Steve Estreich
Thank you for completing this questionnaire
Page 4 of 4